Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

(OP: MDXXF )

0.1314 UNCHANGED
Streaming Delayed Price Updated: 10:18 AM EDT, Oct 31, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about MDXXF

PharmAla to supply Mt. Sinai Hospital with LaNeo MDMA
From PharmAla Biotech
Via GlobeNewswire
PharmAla Launches MDMA Clinical Trial Tool for Researchers
From PharmAla Biotech
Via GlobeNewswire
PharmAla Comments on USFDA Decision regarding MDMA-Assisted Therapy and Announces Patent Granting for ALA-002
From PharmAla Biotech
Via GlobeNewswire
Cortexa Commences Manufacturing GMP LaNeo™ MDMA in Australia
Novel Composition of MDMA Enantiomers leading to next-generation MDMA possibilities 
From PharmAla Biotech
Via GlobeNewswire
Patent Allowance Granted for ALA-002 Composition by US Patent and Trademark Office
Novel Composition of MDMA Enantiomers leading to next-generation MDMA possibilities 
From PharmAla Biotech
Via GlobeNewswire
Patent Allowance Granted for P-1 Molecule by US Patent and Trademark Office
Novel MDMA-Like Drug Could Be Used for Numerous Neurological and Psychiatric Indications 
From PharmAla Biotech
Via GlobeNewswire
Cortexa Leads the World in First Supply of Psilocybin Under the TGA’s Authorized Prescriber Scheme
PharmAla now first company to supply both MDMA and Psilocybin into the Australian Market 
From PharmAla Biotech
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.